or medical castration) for advanced prostate cancer in combination with a luteinizing hormone-releasing hormone analogue or surgical castration.Contents [hide]1 Description2 Indications and useFor the treatment casodex, finasterid stage D2 metastatic prostate cancer in combination with an LHRH analogue casodex, finasterid surgical.

3-(4-fluorophenyl)sulfonyl-2- hydroxy-2-methyl- propanamideIdentifiersCAS number 90357-06-5ATC code L02BB03PubChem 56069DrugBank APRD00042Chemical casodex, finasterid casodex, finasterid mass 430.374 g/molPharmacokinetic dataBioavailability well absorbedProtein binding 96%Metabolism hepaticHalf life 5.8 daysExcretion ?Therapeutic considerationsPregnancy cat. X(US)Legal status ? Prescription onlyRoutes OralBicalutamide (marketed as Casodex®, Cosudex®, Calutide®, Kalumid®) casodex, finasterid an oral casodex, finasterid anti-androgen with the brand names Casodex and Cosudex. Bicalutamide is recommended 50 mg once daily in combination with an LHRH analogue or as a monotherapy. Has casodex, finasterid used in clinical trials for ovarian cancer.[edit] casodex, finasterid and precautions4 Adverse reactions5 External links[edit] DescriptionBicalutamide is an oral non-steroidal anti-androgen with the brand names Casodex and Cosudex. Bicalutamide is recommended 50 mg once daily in combination with an LHRH analogue or as a monotherapy.

56069DrugBank APRD00042Chemical dataFormula C18H14F4N2O4SMol. mass 430.374 g/molPharmacokinetic.